Procurement intelligence

Federal contract award

VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATES SERVICES FOR UP TO 10 YEARS.

EMERGENT BIOSOLUTIONS CANADA INC · Department of Health and Human Services

Value: $422,315,784
Start: May 31, 2019
End: Mar 30, 2027
Action date: Mar 23, 2026
PIID: 75A50119C00037
Status: active
NAICS: 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Place of performance: —
Award type: DEFINITIVE CONTRACT

Description

VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATES SERVICES FOR UP TO 10 YEARS.

Need modifications, related awards, and vendor peers? Open the full award workspace.